Epigenetics has an important role in the regulation of metabolic adaptation to environmental 28 modifications. In this sense, the determination of epigenetic changes in non-invasive samples 29 during the development of metabolic diseases could play an important role in the procedures 30 in primary healthcare practice. To help translate the knowledge of epigenetics to public health 31 practice the present study aims to explore the parallelism of methylation levels between white 32 blood cells and buccal samples in relation to obesity and associated disorders. 
Introduction 48
Obesity prevalence rates increase each year worldwide, resulting in a concomitant rise of 49 associated metabolic diseases [13] . There are many possible causes, including the 50 westernization of the dietary patterns, characterized by an increment of energy-dense food 51 consumption, as well as the wider adoption of sedentary lifestyles, which induce a chronic 52 energy misbalance [48] . Epigenetics appear to be an important dynamic element in the 53 adaptation to environmental changes and in the triggering of specific physiological responses 54 [9] . 55
Several studies have shown that the epigenome has the potential to be modified by exposure 56 to a range of nutritional factors [34] . A study by van Dijk et al, [15] has demonstrated that 57 these epigenetic modifications are associated with a increase risk of developing obesity, as 58 well as other non-communicable diseases such as type 2 diabetes, hypertension, 59
dyslipidaemias or cardiovascular events [12, 16, 35, 43] . Indeed, epigenetic markers, and more 60 specifically DNA methylation levels, may represent a potential marker for disease, which have 61 been studied to identify a predictive role of methylation changes in pathways related to 62 metabolic diseases [34] . Because DNA methylation patterns can be cell-type specific, these 63 studies have investigated changes within specific cell types and tissues, such as white adipose 64 tissue, muscle, pancreas and blood [1, 3, 14, 38, 44, 45, 54] , where the functional effect is 65 assumed to occur [32] . However, in some cases the sampling procedures are invasive and it is 66 not possible to carry out these procedures in primary healthcare practice. For these reasons, 67 and in order to translate the knowledge about epigenetics to public health practice and 68 policies, there is the need to evaluate other tissues [5] . This strategy would facilitate the use of 69 alternative and more feasible techniques from non-invasive tissues, which may "mirror" 70 pattern of epigenetic markers in other specific tissues of interest (i.e., skeletal muscle, liver, 71 adipose tissue, etc). To achieve this goal, research has evaluated the epigenetic modifications 72 of obesity in less invasive and more commonly collected tissues, such as peripheral blood 73 mononuclear cells [8, 20, 33, 53, 56] . Most recently, other studies have analysed DNA 74 methylation patterns in peripheral tissues, blood and subcutaneous adipose tissue, to explore 75 the parallelism in the development of different metabolic disorders related to obesity [24, 45] . 76
Indeed, epigenetic markers in DNA from buccal swabs have been used to characterize novel 77 biomarkers in non-invasive, easily accessible samples. Moreover, buccal samples have been 78 suggested as better informative surrogates than blood for epigenome-wide association studies 79 [27] . 80
The development of high-throughput technologies has also facilitated the analysis of different 81 tissues to compare changes at an epigenomic level, which may have been produced by, or are 82 associated with, metabolic diseases. These methodologies could be used to develop a 83 "personalised nutrition" approach to provide a tailored assessment for the prevention of non-84 communicable diseases, as well as for designing new treatments [6] . 85
Taking into account these premises, we propose to examine the eventual parallelism in DNA 86 methylation levels between white blood cells (WBC) and buccal samples, at specific CpGs 87 concerning obesity and associated disorders. 88
89

Material and methods 90
Study subjects 91
A subset of volunteers were selected from the Spanish cohort of the Food4Me study, which is 92 a randomized, longitudinal, multicentre trial of personalised nutrition advice, delivered 93 through online assessment with four levels of intervention and two intensities [10] . A total of 94 43 volunteers were invited to attend the University of Navarra to validate their self-reported 95 measures carried out during the main study. Anthropometric measurements were taken by 96 trained researchers. Blood samples were also collected after a 10-12 hours overnight fast to 97 perform the biochemical determinations and validate the genetic data. From those 43 98 volunteers a subsample of 10 volunteers were selected to take part in the present study. For 99 this purpose, buccal swaps samples were collected to isolate DNA and to determine DNA 100 methylation levels. Selection of CpG sites: CpG selection was performed using the "Standard Deviation for β-137 values" method, which has been shown to be a robust non-specific procedure in the selection 138 of CpG and in the dimension reduction procedure performed in high-throughput databases, 139 prior to cluster analysis [57] . According to this premise, those CpGs with higher standard 140 deviations were chosen, assuming that those CpGs could be expected to have more biological 141 relevance and variability. In addition a concordance correlation analysis [26] was carried out to 142 measure the agreement between DNA methylation levels in blood and buccal swabs. This 143 method is based on a coefficient correction that rewards the linear fit with origin in 0 and a 144 slope with value 1. This analysis is widely used in the validation of different techniques, giving 145 higher coefficients to those techniques presenting best accuracy and precision, with 1 being 146 the value for perfect fit between measurements. The correlation matrix of these selected CpG 147 was plotted in a heatmap, after unsupervised linkage clustering using Euclidean distances, to 148 visualise the methylation patterns of those CpG with better fit between tissues. 149
Correlation with phenotypical characteristics: Pairwise Pearson and Spearman correlation 150 coefficients between CpGs of both tissues and phenotypical characteristics were estimated to 151 determine the relationship between methylation levels with anthropometrical and 152 biochemical variables. Those CpGs that show association with any phenotypical variable and 153 passed a p-value threshold of 0.01 (which correspond with the minimum common p-value 154 possible for both tissues and tests) in both tissues for Pearson and Spearman tests, were 155 selected for further investigation (Supplementary Figure 1) . 156
The Shapiro-Wilk normality test was used to determine the distribution of phenotypic 157 variables. Accordingly, Student t-test or Mann-Whitney U test were used for parametric and 158 nonparametric continuous variables, respectively. R-Studio software was used to carry out all 159 the analysis and graphics. 160
Pathway analysis 161
The Ingenuity Pathway Analysis (IPA) (IPA software, Ingenuity Systems; Qiagen; Redwood City, 162 CA, USA) system was used to analyse functions potentially involved in obesity or non-163 communicable metabolic disorders. Pathway analysis was conducted on the list of genes from 164 selected CpGs with best fitting in methylation level between tissues, to determine those 165 pathways or functions that could be equally modified in both tissues. Each gene from the list 166 was classified by IPA, according to pathways and functions. Fisher's exact test was used to 167 estimate the likelihood and the p-value of those genes participating in each pathway. 168
Ethics 169
The present investigation was approved by the Research Ethics Committee of the University of 170 Navarra (ref. 041/2012) . The protocol and all the procedures used during this trial are in 171 agreement with the Helsinki Declaration articles, and European and National guidelines for 172
Good Clinical Practices. 173
Results
175
General characteristics: The sample (n=10) was composed of 6 females and 4 males, with a 176 mean age of 36±5 years, and a BMI of 24.2±3.7 kg/m 2 . When the sample was dichotomised 177 into those participants who were normal weight or overweight, defined by the BMI (Table 1) According to the designated criteria for the CpG selection, the standard deviations for each 188 tissue were plotted to determine the β-value range for the collection (Figure 1c and 1d) . Those 189
CpGs with a standard deviation higher than 0.2, in at least one of the tissues, were used for 190 subsequent analyses. In order to prevent discordances between tissues, concordance 191 correlation analysis was carried out. The CpGs with higher concordance coefficient (higher 192 than 0.9) were those which best fitted the diagonal line correlation between tissues. Finally, a 193 total of 277 CpGs met both criteria and were selected for further analysis (Sup. between phenotypical variables when the p-value threshold was reduced to 0.05 for both tests 217 and tissues (cg20473595 in ATP2A3 for HOMA index and cg16957758 in ADARB2 for leptin 218
levels) 219
Discussion 220
In agreement with previous studies, the current investigation identified specific CpG sites 221 which showed similar methylation patterns in both tissues and which were related to obesity 222 and metabolic functions, as corroborated with the enrichment software IPA [23] . Methylation 223 of the gene GAP43 (Growth Associated Protein 43) was inversely correlated with BMI. The 224 protein encoded by GAP43 is involved in neuronal regeneration and plasticity, but studies in 225 rats have shown that obesity or diabetes can affect its expression [4, 52] . We observed a 226 statistically significant correlation between circulating leptin levels and methylation of a CpG 227 located in double-stranded RNA-specific editase B2 (ADARB2) gene which is associated with 228 longevity in humans [40, 46] . Polymorphisms in ADARB2 are associated with higher abdominal 229 circumference, BMI and triglyceride levels [40] , but also with lower adiponectin concentration 230 [39, 40] . Accordingly, Oguro et al proposed that changes in ADARB2 expression in the thalamus 231 and amygdala could trigger changes in feeding behavior that promote visceral fat 232 accumulation [40] . Finally, a correlation between the HOMA index and the methylation levels 233 of a CpG site located in the gene body of ATP2A3 was found. This gene encodes for one of the 234 SERCA Ca(2+)-ATPases that has been described to be involved in calcium homeostasis in 235 pancreatic cells [51] . Also, methylation changes in CpGs of this gene have been recently 236 described to be associated with changes in insulin in muscle samples from non-diabetic 237 subjects. [36] . Furthermore, changes in the expression of ATP2A3 isoforms has been also 238 related with endoplasmic reticulum stress and changes in cell adhesion capacity [11] . 239 Some studies suggest the feasibility of using epigenetic markers as an early biomarker of 240 increased risk of specific diseases [6, 15] . Given the worldwide increase in prevalence of 241 obesity and of obesity-related complex disorders, such as impaired glucose homeostasis, 242 dyslipidaemias, or hypertension, which are modulated by both genetic and environmental 243 factors, further research on early biomarkers may help to monitor and screen for the onset 244 and progress for these diseases [7] . 245
In response to those demands, some studies are already linking epigenetic marks and obesity 246 [2, 12, 16, 34, 43] . However, the routine collection of appropriate samples from specific tissues 247 for determining the developmental status of these disorders, may be a difficult task in normal 248 clinical practice [5] . For these reasons, there is a need to identify alternative, non-invasive 249 sample sources on which accurately reflect related methylation marks. When such tissues have 250 been identified and validated, this biomarker approach may be applied in screening and 251 monitoring of obesity-related disorders. Consequently, the determination of epigenetic marks 252 that are modified in other non-specific tissues provides the opportunity of delivering 253 personalised procedures in clinical practice [47] . Indeed, some authors have proposed the idea 254 of using these epigenetics marks as a screening tool, to predict the risk of future disease [17, 255 22] . For the application of these biomarkers in the clinical practice, it would be convenient that 256 they are obtained from non-invasive procedures (such as buccal swabs), if it is confirmed that 257 these mirror the epigenetic markers in the target tissues. In this context, differences in 258 methylation patterns between tissues need to be further investigated [28, 32] . 259
The development of studies that provide evidence to support the use of epigenetic marks in 260 specific tissues as a surrogate of epigenetic status in non-invasive tissues will improve the 261 efficiency of clinical practice [5] . In this aspect, it is also necessary to find tissues with enough 262 cell type homogeneity in order to diminish the effects of confounding changes that could be 263 occurring in tissues such as blood, where the health or diseases status can alter the proportion 264 of white cells present, which may hamper the comprehension of epigenetic marks [31, 49] . For 265 this reasons, our study provides support for the idea that methylation of DNA obtained from 266 buccal cells may be used to identify new markers related to metabolic disorders in a 267 homogenous cell type sample. Findings from the present study also allow identification of 268 alterations in the digestive tract, facilitating investigation of impairments in digestion, 269 absorption and different related disorders, such as inflammatory intestinal disorders [30, 58] . 270
At the same time, some studies have revealed the stability of epigenetic marks over time [17] . 271
Although some studies have reported discordance in DNA methylation results when comparing 272 two accessible human tissues such as peripheral blood mononuclear cells and buccal epithelial 273 cells [25] , other trials have suggested that, for epigenetic population studies, buccal swabs are 274 likely to be a more informative surrogate tissue than blood [27] . In the same way, it is very 275 important to take into account other possible habits that could affect the methylation levels in 276 this surrogated tissues, such as smoking behaviour, which has been shown to be associated 277 with changes in specific methylation sites, in buccal mucosa samples used as a surrogate 278 tissue, that were previously associated with changes in expression of genes related with 279 smoking -related lung diseases [55] . 280
Our findings add to the evidence from other recent studies that aimed to associate epigenetic 281 marks in different tissues with metabolic disorders. For example, Ronn et al [45] tried to 282 determine the effects of age, BMI, and glucose status on DNA methylation and RNA expression 283 levels in adipose tissue and peripheral blood samples. These authors also used a wide coverage 284 array to analyse the methylation levels, and they found a large number of genes whose 285 methylation levels correlated with BMI and HbA1 levels in both tissues. In contrast, other 286 recent epigenome-wide profilings of methylation levels have described different genes that 287 could act as mirror markers in paired blood and adipose tissue samples [24] . However, the 288 authors reported lack of association between DNA methylation levels in blood and weight 289 status, suggesting that blood markers do not mirror adipose tissue markers [24] . Using both 290 blood and buccal samples, Talens et al investigated the relationship between DNA methylation 291 levels and obesity, and proposed that the study of complex disorders could be feasible with 292 well-designed studies [49] . Other researches have used buccal samples in the search for 293 methylation signatures in childhood psychotic symptoms [18] , the response to prenatal 294 exposure of maternal cigarette smoking [37] or the symptoms observed in children with fetal 295 alcohol spectrum disorder [42] . 296
The present work proposes the use of surrogate methylation markers in buccal swab samples 297 in relation to obesity, to provide a more accessible tissue than peripheral blood cells to 298 perform future analyses in clinical practice, with the benefit of no need of venous puncture 299 and the feasibility of storage of the sample before the extraction. The main limitation of the 300 present work is the small number of volunteers, but the wide coverage of the methylation 301 analysis and the selection methods performed are strengths. For these reasons, this study 302 provides the bases for the future development of DNA methylation analyses in buccal swab 303 samples as possible surrogate markers for investigation in obesity and related comorbidities. 304
These findings show the potential application of a non-invasive approach in the identification 305 of surrogate epigenetic biomarkers. Particularly, this study opens the door to further analysis 306 of the roles of GAP43, ATP2A3 and ADARB2 in relation to weight management. 307
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